Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
735 Results for "
beta2
" in MedChemExpress (MCE) Product Catalog:
Products (735)
735 Results for "beta2" in MCE Product Catalog:
2
2 Cited Publications
Cat. No.: HY-100704
CAS No.: 62929-91-3
Target:
Research Areas:
Procaterol hydrochloride is a selective intermediate-acting β2 adrenoreceptor agonist with an EC50 of 12.9 μM . Procaterol hydrochloride can inhibit inflammation both in vivo and in vitro [2].
2
2 Cited Publications
Target:
Research Areas:
L748337 is a potent β3-adrenergic receptor antagonist and displays selectivity over β1 and β2 receptors. The Ki values of L748337 for β3-, β2- and β1-adrenoceptors are 4.0 nM, 204 nM and 390 nM, respectively . L748337 couples predominantly to Gi to activate MAPK signaling and increases phosphorylation of Erk1/2 with pEC50 value of 11.6 [2]. L748337 can be used for the research of cancer, nonalcoholic fatty liver disease (NAFLD), and cardiovascular related diseases [2] .
2
2 Cited Publications
Synonyms: Cytisine; Sophorine; Baptitoxine
Category:
Alkaloids Pyridine Alkaloids Metabolic Disease Leguminosae Extract Plants Thermopsis lanceolala R.Br. Disease Research Fields
Target:
2
2 Cited Publications
Synonyms: S44819; Egis-13529
Target:
Research Areas:
Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. Afizagabar enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy .
2
Target:
Research Areas:
PNU-120596 (NSC 216666) is a potent and selective α7 nAChR positive allosteric modulator (PMA) that can cross the blood-brain barrier, with an EC50 of 216 nM. PNU-120596 is inactive against α4β2, α3β4, and α9α10 nAChRs. PNU-120596 has the potential for psychiatric and neurological disorders research .
2
Target:
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P76143
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PRKAG1; 5'-AMP-Activated Protein Kinase, Gamma-1 Subunit; Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 1; AMPK Subunit Gamma-1; 5'-AMP-Activated Protein Kinase Subunit Gamma-1; AMPK Gamma-1 Chain; Protein Kinase, AMP-Activated, Gamma 1 Non-Cat
Species:
Human
Source:
Sf9 insect cells
1
1 Cited Publications
Cat. No.: HY-P74834
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL12RB2; IL-12R Subunit beta-2; Interleukin 12 Receptor Subunit beta 2; Interleukin-12 Receptor beta-2 Chain; Interleukin-12 Receptor Subunit beta-2; IL-12R-beta-2; Interleukin 12 Receptor, beta 2; IL-12RB2; IL-12 Receptor Subunit beta-2
Species:
Mouse
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P71131
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TPSB2; Tryptase beta III; Tryptase beta 2; Tryptase beta II; Testicular Tissue Protein Li 163; TPSB2 Protein; Tryptase beta-2; Tryptase II; TPS2; Tryptase-2; Tryptase beta 2 (Gene/Pseudogene); TryptaseB; Mast Cell Tryptase beta III; TryptaseC; Mast Cell T
Species:
Mouse
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P81085
Synonyms: beta 2-adrenergic receptor; beta 2 Adrenergic Receptor; ADRB2R; ADRBR; ADRB2_HUMAN; Adrenergic beta 2 receptor surface; B2AR; BAR; beta 2 adrenoreceptor; beta2AR; Catecholamine receptor; beta2-adrenergic receptor. β2-adrenergic receptor;
1
1 Cited Publications
Cat. No.: HY-P7378
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, beta 2; CTL Differ
Species:
Mouse
Source:
CHO
1
1 Cited Publications
Cat. No.: HY-P7044B
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, beta 2; CTL Differ
Species:
Human
Source:
E. coli
1
1
1 Cited Publications
Cat. No.: HY-P78854
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, beta 2; CTL Differ
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P700216AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; Interferon, beta 2; CTL Differ
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P7533
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: APOH; Anticardiolipin Cofactor; Prev. B2G1; beta(2)GPI; beta-2-Glycoprotein I; B2GPI; beta-2-Glycoprotein 1; Apo-H; BG; Epididymis Secretory Sperm Binding Protein; Apolipoprotein H (beta-2-Glycoprotein I); B2GP1; Activated Protein C-Binding Protein; Apoli
Species:
Human
Source:
HEK293
1
Target:
Research Areas:
Arformoterol ((R,R)-Formoterol), the (R,R)-enantiomer of Formoterol, is a long-acting β2-adrenergic receptor (β2-AR) agonist, with a Kd of 2.9 nM. Arformoterol can be used for the research of chronic obstructive pulmonary disease (COPD) [2].
1
1 Cited Publications
Target:
Research Areas:
LU-002i is a subunit-selective human proteasome β2c and β2i inhibitor with an IC50 value of 220 nM for β2i .
1
Target:
Research Areas:
Arformoterol ((R,R)-Formoterol) tartrate, the (R,R)-enantiomer of Formoterol, is a long-acting β2-adrenergic receptor (β2-AR) agonist, with a Kd of 2.9 nM. Arformoterol tartrate can be used for the research of chronic obstructive pulmonary disease (COPD) [2].
1
1 Cited Publications
Target:
Research Areas:
bPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
